Coherus Biosciences Inc (NASDAQ:CHRS) shares, rose in value on Wednesday, March 26, with the stock price down by -5.81% to the previous day’s close as strong demand from buyers drove the stock to $0.90.
Actively observing the price movement in the last trading, the stock closed the session at $0.96, falling within a range of $0.895 and $0.961. The value of beta (5-year monthly) was 0.925 whereas the PE ratio was 5.18 over 12-month period. Referring to stock’s 52-week performance, its high was $2.61, and the low was $0.66. On the whole, CHRS has fluctuated by -22.05% over the past month.
With the market capitalization of Coherus Biosciences Inc currently standing at about $104.79 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-09.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 103.15M, with a low estimate of 52.36M and a high estimate of 72M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 59.79M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CHRS’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CHRS currently trading nearly -8.17% and -19.06% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.87, while the 7-day volatility ratio is showing 11.08% which for the 30-day chart, stands at 9.96%. Furthermore, Coherus Biosciences Inc (CHRS)’s beta value is 0.94, and its average true range (ATR) is 0.10.
A comparison of Coherus Biosciences Inc (CHRS) with its peers suggests the former has fared considerably weaker in the market. CHRS showed an intraday change of -5.81% in last session, and over the past year, it shrunk by -61.19%%.
Data on historical trading for Coherus Biosciences Inc (NASDAQ:CHRS) indicates that the trading volumes over the past 10 days have averaged 2.39 and over the past 3 months, they’ve averaged 2.01 million. According to company’s latest data on outstanding shares, there are 115.61 million shares outstanding.
Nearly 3.98% of Coherus Biosciences Inc’s shares belong to company insiders and institutional investors own 54.15% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 32.55 million shares as on 2025-03-14, resulting in a short ratio of 18.43. According to the data, the short interest in Coherus Biosciences Inc (CHRS) stood at 3276.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 31.81 million. The stock has fallen by -34.48% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CHRS stock heading into the next quarter.
